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Natural killer (NK) cells belong to the innate immune system and play a central role
in the defense against viral infections and cancer development, but also contribute to
shaping adaptive immune responses. NK cells are particularly important in the first line
defense against herpesviruses, including alphaherpesviruses. In addition to their ability to
kill target cells and produce interferon-γ, porcine and human NK cell subsets have been
reported to display features associated with professional antigen presenting cells (APC),
although it is currently unclear whether NK cells may internalize debris of virus-infected
cells and whether this APC-like activity of NK cells may stimulate proliferation of antiviral
T cells. Here, using the porcine alphaherpesvirus pseudorabies virus (PRV), we show
that vaccination of pigs with a live attenuated PRV vaccine strain triggers expression
of MHC class II on porcine NK cells, that porcine NK cells can internalize debris from
PRV-infected target cells, and that NK cells can stimulate proliferation of CD8+ and
CD4+CD8+ PRV-experienced T cells. These results highlight the potential of targeting
these NK cell features in future vaccination strategies.
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INTRODUCTION
Natural killer (NK) cells, members of the innate immune system, play an indispensable role
in the defense against viral infections and cancer development, mainly because of their ability
to kill virus-infected cells and malignant cells and their ability to produce cytokines, especially
interferon-γ (IFNγ). NK cells are particularly important in the first line defense against
herpesviruses, including alphaherpesviruses (1). Indeed, patients with NK cell deficiencies have
been reported to suffer from aggravated and sometimes life-threatening alphaherpesvirus disease,
including herpes simplex virus (HSV) encephalitis (2–5). The development of HSV vaccines
has proven particularly cumbersome, and has not been successful yet (6, 7). Designing effective
HSV vaccines may require new approaches, targeting previously underestimated elements of the
immune response. It has been pointed out that the activity of NK cells may be an underappreciated
facet of HSV vaccine design (8). Interestingly, for pseudorabies virus (PRV), a close relative of HSV
in pigs, vaccination using live attenuated vaccines has been very successful (9–11).
We and others described that in addition to their well-known functions, porcine and human NK
cell subsets also display features that are typically associated with professional antigen presenting
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cells [APCs; (12–14)]. Indeed, we recently found that, like human
NK cell subsets, porcine NK cells show cell surface expression
of MHC class II and the co-stimulatory molecules CD80/86
(14). In addition, using the NK-susceptible cell line K562, we
found that porcine NK cells may take up debris of killed target
cells and using an allogeneic T cell proliferation assay, we
showed that porcine NK cells may trigger T cell proliferation
(14). Interestingly, human NK cells have been suggested to
directly present HSV antigen to T cells in recurrent herpetic
lesions, thereby stimulating the antiviral T cell response (15).
This has contributed to the idea that targeting NK cells in
alphaherpesvirus vaccinationmay be particularly promising (15).
Thus far, it has not been investigated whether
alphaherpesvirus vaccination may trigger expression of MHC
class II and/or CD80/86 on NK cells, whether NK cells may take
up debris of killed alphaherpesvirus-infected cells and whether
indeed NK cells may stimulate proliferation of alphaherpesvirus-
experienced T cells. Answers to these questions are of paramount
importance to be able to address the potential of targeting these
NK cell features in putative vaccination strategies. The current
study aimed at clarifying these issues.
METHODS
Vaccination Procedure
For primary vaccination, three 10-weeks-old pigs (crossbred
female pigs derived from Rattlerow-Segher hybrid sows and
Pietrain boars) received oronasal (4 × 107 TCID50) and
intramuscular (4 × 107 TCID50) doses of live-attenuated PRV
vaccine strain Begonia diluted in PBS. Three age-matched
control pigs were vaccinated with PBS. Four weeks post primary
vaccination, pigs received a booster vaccination, identical to
the primary vaccination. Again, control pigs were vaccinated
with PBS. The animal vaccination experiment and vaccination
procedure were approved by the Ethical Committee of the Faculty
of Veterinary Medicine (EC2017/119).
Viruses
PRV NIA3 and Kaplan strains were used to infect swine kidney
(SK) target cells. PRV Kaplan wild type virus was kindly provided
by Thomas Mettenleiter (Friedrich Loeﬄer Institute). PRV NIA3
wild-type virus and NIA3-derived attenuated Begonia strain (gE-
deleted and TK-negative, 10) were kindly provided by the ID-
DLO, the Netherlands.
Virus Neutralization Test
Blood was collected in Vacutest Kima gel and clot activator tube
(Vacutest Kima, Arzergrande, Italy), following themanufacturer’s
instructions. Serum samples were heat-inactivated for 30min
at 56◦C. For detection of PRV-specific antibodies a virus
neutralization test was used, as described before (16). Briefly, a
two times dilution series (1/2 to 1/256) was made in duplicate
in Modified Eagle Medium in microtitre plates. Afterwards,
50 µl PRV dilution containing 100 plaque forming units PRV
Abbreviations: DP, double positive; PBMC, peripheral blood mononuclear cell;
PRV, pseudorabies virus; SK, Swine Kidney; WT, wild type.
was added to the serum dilution and incubated for 1 h at
37◦C. Thereafter, 100 µl Porcine Kidney 15 cell suspension
in Modified Eagle Medium, supplemented with 10 % fetal
calf serum, penicillin (1,000 U/ml), gentamicin (50µg/ml) and
fungizone (250 ng/ml), was added to each well followed by an
incubation of 4 days at 37◦C. Plates were then examined for
the presence of plaques and the neutralizing titer of each serum
sample was defined as the highest serial dilution that was capable
of completely neutralizing the virus.
Primary Porcine NK Cell Isolation and
Culture
Heparinised blood samples (50 units/ml blood, LEO Pharma)
were obtained from the external jugular vein of pigs (9–22
weeks old). The blood sampling procedure was approved by
the Ethical Committee of the Faculty of Veterinary Medicine
(EC2017/119 for vaccinated animals and EC2013/62 for healthy
blood donors). Primary porcine NK cells were isolated from
porcine peripheral bloodmononuclear cells (PBMCs) by negative
MACS depletion of CD3+ and CD172a+ cells followed by
FACS purification using antibodies against porcine CD172a
[IgG1, clone 74-22-15a, (17)], CD3 [IgG1, clone PPT3, (18)],
and CD8α [IgG2a, clone 11/295/33, (19)] as described before
(14). Antibodies were kindly provided by Dr. A. Saalmüller and
produced in-house. Porcine NK cells were purity sorted, based on
CD3−CD172a−CD8α+ expression using a BD FACS Aria III Cell
Sorter (BD Biosciences), resulting in a ≥98% pure porcine NK
population.
For the experiments where autologous T cells were needed,
primary porcine NK cells were isolated from porcine PBMC by
negative MACS depletion of CD6+ cells, by using anti-CD6 mAb
[IgG1, clone a38b2; (20)] (see below) followed by FACS using the
same antibodies as described above.
1 × 106 primary porcine NK cells were cultured in 96-
well flat bottomed plates (Nunc, Thermo Fisher Scientific)
in RPMI (Gibco), supplemented with 10% (v/v) fetal calf
serum (Thermo Fisher Scientific), 100 U/ml penicillin (Gibco),
100µg/ml streptomycin (Gibco) (referred to as porcine NK
medium). For cytolytic assays, porcine NK cells were primed with
recombinant human (rh) IL-2 (20 ng/ml) for 16–18 h before the
assay. For T cell proliferation experiments, porcine NK cells were
primed with WT PRV NIA3 strain (5 × 107 TCID50/ml) for
16–18 h before the assay.
Primary CD6+ T Cell Isolation
Porcine CD6+ T cell isolation was performed as described before
(14, 21). CD6+ T cells were enriched from PBMCs to a purity
of >95% by positive immunomagnetic selection with the anti-
CD6 mAb [IgG1, clone a38b2; (20)] and goat anti-mouse IgG1
microbeads and using LS columns.
Cell Surface Expression Analysis via Flow
Cytometry
For flow cytometric analysis, cells were washed in PBS. All
incubation steps were performed in 96-well conical bottomed
plates for 40min at 4◦C. The different combinations of primary
monoclonal antibodies (mAbs) and secondary reagents used for
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TABLE 1 | Primary and secondary antibodies used for cell surface expression analysis by flow cytometry.
Antigen Clone Isotype/recombinant Labeling strategy
APC PHENOTYPING OF NK CELLS
CD3 (18) PPT3 IgG1 Secondary antibody
R-phycoerythrin conjugated
goat anti-mouse IgG1
CD172a (17) 74-22-15a IgG1 Secondary antibody
R-phycoerythrin conjugated
goat anti-mouse IgG1
CD8α (19) 11/295/33 IgG2a Biotin-streptavidin
Allophycocyanin
CD80/86 Recombinant human CD152 [CTLA-4]-muIg
fusion protein mouse IgG2a
(Ancell, Bayport, MN)
Directly labeled
Fluorescein isothiocyanate conjugated
MHC II (Bio-Rad) 2E9/13 IgG2b Secondary antibody
Alexa fluor 488 conjugated goat anti-mouse IgG2b
PROLIFERATION ASSAYS
CD3 (18) PPT3 IgG1 Secondary antibody
R-phycoerythrin conjugated
goat anti-mouse IgG1
CD8α (19) 11/295/33 IgG2a Secondary antibody
Alexa Fluor 647 conjugated
goat-anti-mouse IgG2a
CD4 (17) 74-12-4 IgG2b Secondary antibody
Fluorescein isothiocyanate conjugated goat anti-mouse IgG2b
each assay are listed in Table 1 and were diluted in PBS. Sytox
blue (Thermo Fisher Scientific) was used to discriminate live and
dead cells for the APC phenotyping of NK cells. Flow cytometry
was performed using a BD FACS Aria III (BD Biosciences), and
samples were analyzed with FACSDiva software (BD Biosciences)
and FlowJo software (doublet discrimination). Minimum 10,000
NK cells were analyzed for the APC phenotyping, minimum
20,000 T cells in the recall PBMC assay and minimum 1,000 T
cells/subset were analyzed in theNK/T proliferation experiments.
Infections of Swine Kidney (SK) Cells
SK cells were used as target cells in cytolytic assays and
were cultivated in Modified Eagle Medium (Life Technologies,
Thermo Fisher Scientific) supplemented with 10% (v/v) fetal calf
serum, 100 U/ml penicillin, 100µg/ml streptomycin and 0.05
mg/ml gentamycin. SK cells were detached from cell culture
flasks (175 cm2) using trypsin, seeded in suspension culture
flasks (25 cm2, Sarstedt, Nümbrecht, Germany) at 1.2 × 107
cells/8.5mL, inoculated at a multiplicity of infection of 10, and
put on a rocking platform at 37◦C for 12 h.
Cytolytic and Internalization Assays
Mock or PRV wild type NIA3- or wild type Kaplan-infected
SK cells were labeled with carboxyfluorescein succinimidyl ester
(CFSE) proliferation dye (CellTrace
TM
CFSE cell proliferation
kit; Invitrogen, Thermo Fisher Scientific) according to the
manufacturer’s recommendations. Briefly, 1.0 × 106 SK cells/ml
were resuspended in porcine NK medium with 5µM CFSE and
incubated during 15min at 37◦C. The labeling reaction was
stopped by addition of ice-cold porcine NKmedium. Afterwards,
CFSE-labeled SK cells were washed in porcine NK medium
to remove excess CFSE. SK cells were co-incubated with IL-
2-primed NK cells at an effector:target ratio of 25:1 for 2–8 h
(as indicated in the text) at 37◦C. For internalization assays,
subsequently, cells were washed 2 times with 1ml PBS, fixed
with 3% paraformaldehyde (PFA), washed 2 times with 1ml PBS,
incubated for 40min at 37◦C with anti-CD16 mAb (IgG1, clone
G7, AbD Serotec), washed 2 times with 1ml PBS, incubated
for 40min at 37◦C with goat anti-mouse IgG1 Alexa Fluor 647
(Thermo Fisher Scientific) and washed 2 times with 1ml PBS.
Flow cytometry was performed using a BD FACS Aria III, and
samples were analyzed with FACSDiva software and FlowJo
software (doublet discrimination).
For cytolytic assays, after co-incubation at an effector:target
ratio of 20:1 for 4 h, viability of 5,000 target cells was assessed
by propidium iodide and flow cytometry. The percentage of NK-
mediated lysis was calculated using the formula (% dead targetNK
– % dead targetspont)/(%dead targetmaximum – % dead targetspont).
Proliferation Assays
Isolated PBMCs or primary CD6+ T cells were labeled with
violet proliferation dye (CellTrace
TM
Violet cell proliferation kit;
Life Technologies, Thermo Fisher Scientific) according to the
manufacturer’s recommendations. Briefly, 1.0 × 106 CD6+ T
cells or PBMCs/ml were resuspended in PBS with 5µM violet
dye and incubated for 20min at 37◦C. The labeling reaction
was stopped by addition of ice-cold mixed leukocyte reaction
medium, consisting of DMEM (Life Technologies, Thermo
Fisher Scientific), supplemented with 10% (v/v) fetal calf serum,
100 U/ml penicillin and 100µg/ml streptomycin. Excess dye
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was removed by two mixed leukocyte reaction medium washing
steps. Thereafter, for the recall PBMC assay, 1× 106 PBMCs were
cultured in a 96-well flat-bottomed plate with PRV WT NIA3 (1
× 107 TCID50) for 4 days.
For the T/NK proliferation experiments, 4 weeks post-booster
vaccination, PRVWTNIA3-stimulated NK cells (1.2× 105) were
co-cultured in a round bottomed plate with medium, mock- or
PRV WT NIA3-infected target SK cells at an effector:target ratio
of 20:1, followed by adding 1.2 × 105 violet dye-labeled CD6+
T cells per well after 2 h co-incubation, during 4 days in the
presence of rh IL-2 (20 ng/ml)(added on the first day).
Statistical Analysis
Statistical analysis was performed using Graphpad Prism 5. Data
were analyzed for statistical differences with an unpaired t-
test at the 5% significance level to compare two conditions.
To compare more than two conditions, data were analyzed
for statistical differences with a repeated measures analysis
of variance (ANOVA) at the 5% significance level. Post-hoc
comparisons between different conditions were performed using
Tukey’s range test.
RESULTS
Porcine NK Cells Internalize Debris Derived
From Killed PRV-Infected Target Cells
Recently, using the NK-susceptible cell line K562, we showed
that porcine NK cells are able to perform actin polymerization-
dependent internalization of cell debris derived from their killed
target cells (14). Here, we investigated whether porcine NK
cells may also internalize debris from killed PRV-infected target
cells, which is an important prerequisite for potential antigen
presenting properties of porcine NK cells in the context of an
alphaherpesvirus infection.
To test this, primary porcine NK cells of healthy blood donors
were used in cytolytic assays using CFSE-labeled mock-infected
and wild type (WT) PRV-infected swine kidney (SK) target cells.
SK cells were infected at a MOI of 10 which we showed earlier to
result in a 100% infection rate (22). Infection rate was confirmed
for each assay by cell surface staining of viral protein gD and
flow cytometric analysis and was always 100% (data not shown).
Earlier, we also have shown that co-incubation of NK cells with
PRV-infected or mock-infected SK cells leads to preferential
killing of PRV-infected SK cells compared to mock-infected cells
(23, 24).
At different time points post co-incubation of NK and target
cells, NK cells were analyzed by flow cytometry for CFSE
fluorescence as an indication for internalization of target cell
debris, as described earlier for killed K562 target cells (14).
To ensure that NK cells do not take up free CFSE from lysed
target cells which has not covalently bound to cellular proteins,
a control experiment was performed where NK cells were
incubated for 2 h with either CFSE-labeled K562 cells or with
supernatant of CFSE-labeled K562 cells that had been incubated
before for 2 h with NK cells to trigger K562 cell killing. NK cells
incubated with supernatant of killed CFSE-labeled K562 cells did
not become CFSE positive (Supplemental Figure 1).
After 2 h of co-incubation of NK cells with CFSE-labeled
PRV-infected or mock-infected SK cells, a statistically significant
higher amount (mean ± SD) (8.1 ± 2.1%) of CFSE-positive NK
cells were detected upon co-incubation with PRV-infected target
cells compared to co-incubation with mock-infected cells (2.4 ±
0.7%), indicative for internalization of debris derived from PRV-
infected target cells by the NK cells (Figure 1). This increase in
the number of CFSE-positive NK cells was followed by a gradual
decrease (from 7.2± 3.0% at 4 h to 4.7± 1.9% at 8 h) (Figure 1),
all in line with earlier results in K562 cells (14), suggesting
that NK cells are able internalize debris and further process the
internalized debris of PRV-infected target cells.
In conclusion, porcine NK cells can internalize antigens
derived from PRV-infected target cells, suggesting they may be
able to present PRV antigens to T cells.
APC Markers on the Surface of Porcine NK
Cells Are Upregulated After Primary PRV
Vaccination but Not After Booster
Vaccination
Ten-week-old pigs were vaccinated with the live attenuated PRV
vaccine strain Begonia followed by a booster vaccination 4 weeks
later. Mock-vaccinated animals (vaccinated with PBS) served
as controls. Figures 2A,B show that all PRV-vaccinated, but
not the mock-vaccinated animals, developed PRV-specific serum
antibodies and T cell responses based on recall PBMC assays,
indicating successful vaccination. Serum antibodies and T cell
responses could already be detected after primary vaccination,
and were increased upon booster vaccination.
In a next step, we investigated whether the APC phenotype of
NK cells is affected upon vaccination of pigs with a live attenuated
vaccine. At different time points (3 days before vaccination, 1,
3, and 18 days post primary vaccination, and 1 and 3 days post
booster vaccination), PBMCs were isolated and NK cells within
the PBMC population from mock- and PRV-vaccinated animals
were tested for their surface expression of the APC markers
MHC class II and CD80/86 (Figures 3A–C). NK cells were gated
based on their CD3−CD172a−CD8α+ expression profile. Data
are shown as the median fluorescence intensity (MFI) value of
each time point for each animal compared to the MFI before
vaccination (pre-vaccination—set to 100%) for this animal.
Figure 3B shows a statistically significant upregulation of MHC
class II expression on the NK cell surface at 3 days after primary
vaccination (Figure 3B), which was not observed in the control
animals. The MHC class II upregulation was associated with a
cell surface upregulation of CD80/86 expression in the PRV-
vaccinated group at 3 days post primary vaccination, although
this upregulation was not statistically significant (Figure 3C).
This upregulation of cell surface MHC class II (and CD80/86)
on NK cells was only observed early after primary vaccination,
and not later post primary vaccination (18 days) or after booster
vaccination (Figures 3B,C).
We also tested whether the percentage of NK cells in blood
changes after PRV vaccination. Although substantial individual
variability in NK cell percentage in blood could be observed over
time, no obvious differences or trends could be observed over
time in either PRV- or mock-vaccinated animals (Figure 3D).
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FIGURE 1 | Porcine NK cells internalize fragments of killed PRV-infected target cells. (A) Histograms show the CFSE signal of IL-2-primed NK cells that were
incubated for the indicated times with PRV WT-infected SK cells (NK:target ratio 25:1) that had been labeled with CFSE (red open histogram), CFSE-labeled
mock-infected SK cells (black open histogram) or not incubated with target cells (gray shaded histogram) of one representative pig (out of three). The amount of
CFSE-positive cells (%) is indicated in the histograms. (B) Graph shows the amount of CFSE-positive IL-2-primed NK cells that were co-incubated for the indicated
times with CFSE-labeled mock-infected SK cells or PRV wild type-infected SK cells (effector target ratio of 25:1). Dot plot shows the results of three individual blood
donors and the mean values are connected with a line. P-value threshold for statistically significant differences was 0.05, p-values are indicated in the graphs.
All together, these data suggest that the APC cell surface
markers of NK cells are triggered early upon primary vaccination
against the porcine alphaherpesvirus PRV, but not after booster
vaccination with the same vaccine.
PRV Primed Porcine NK Cells Stimulate T
Cell Proliferation of PRV-Experienced
CD8+ and CD4+CD8+ T Cells Upon Killing
of PRV-Infected Target Cells
The data above suggest that in particular circumstances, porcine
NK cells may have the potential to stimulate PRV-specific T
cells during PRV vaccination/infection. Hence, we investigated
whether NK cells, upon killing of PRV-infected target cells, may
be able to stimulate proliferation of PRV-experienced T cells.
Since 2 h co-incubation of NK cells with PRV-infected cells leads
to maximal internalization of target cell debris [Figure 1 and
(14)], NK cells derived from blood of PRV-vaccinated or mock-
vaccinated animals were incubated with PRV-infected or mock-
infected SK cells for 2 h before addition of T cells. In line with
earlier findings (23, 24), PRV-infected SK cells show increased
susceptibility to NK cell-mediated lysis, compared to mock-
infected SK cells (Figure 4A). As a control, we confirmed that
the killing efficiency of PRV-infected SK cells was similar for
PRV-stimulated NK cells derived from either PRV-vaccinated or
mock-vaccinated animals (Figure 4A). At 2 h post incubation
of NK cells with PRV- or mock-infected SK cells, autologous
T cells were added to the co-culture for 4 days and T cell
proliferation was determined. Conditions with T cells alone, T
cells co-incubated with mock/PRV-infected SK cells but without
NK cells and T cells co-incubated with NK cells but without SK
cells served as controls.
Proliferation of CD3+ T cells was very low to virtually
absent in all control conditions: T cells alone, T cells in the
presence of mock- or PRV-infected SK cells alone or T cells in
the presence of NK cells and mock-infected SK target cells. A
statistically significant NK cell-dependent increase in CD3+ T
cell proliferation could be observed in the condition where NK
cells were able to kill PRV-infected SK cells, but only when T
cells were derived from blood of PRV-vaccinated pigs, but not
when T cells were derived from PRV-naïve (mock-vaccinated)
animals (Figure 4B). This indicates that NK cells that are allowed
to internalize debris from PRV-infected SK target cells are able to
stimulate proliferation of PRV-experienced T cells.
In vitro proliferation of PRV-experienced T cells in PRV-
primed mixed leukocyte assays has been shown to result in
the proliferation of CD8+ and CD4+CD8+ double positive
(DP) T cell fractions (25). The latter population is of particular
importance in pigs, as it can trigger memory responses (26,
27). Therefore, we analyzed whether porcine NK cells can
contribute to the proliferation of these two specific populations.
Supplemental Figure 2 shows the gating strategy to discriminate
the different T cell subsets.
Both CD8+ and CD4+CD8+ DP T cell fractions showed
a significantly increased NK cell-dependent proliferation
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FIGURE 2 | PRV vaccination induces PRV-experienced T cells and seroconversion. (A) Flow cytometry analysis of violet labeled PRV-stimulated PBMC isolated from
mock-vaccinated pigs (n = 3) and PRV-vaccinated animals (n = 3) at 18 and 14 days post primary and booster vaccination, respectively, is shown. Dot plots show the
proliferation-induced dilution of the violet level of the CD3+ T cell fraction after 4 days. (B) Seroconversion in mock-vaccinated and PRV-vaccinated pigs was tested
by a virus neuralization assay at different timepoints: pre-vaccination, 18 days post primary vaccination, and 14 days post booster vaccination. The log equivalent of
the serum dilution able to neutralize 100 PFU PRV is reported as the neutralization titer. Dot plot shows the results of the three animals in each group (mock- and
PRV-vaccinated) and the mean values are connected with a line.
when using PRV-infected SK target cells and T cells from
PRV-vaccinated animals, when compared to using mock-
infected SK target cells (Figures 4C,D). No increase in CD4+ T
cell proliferation was observed in these conditions (Figure 4E).
Violet proliferation dot plots of T cells of one PRV-vaccinated
animal are shown in Supplemental Figure 3.
In conclusion, these data show that upon killing of
PRV-infected target cells, porcine NK cells are able to stimulate
proliferation of PRV-experienced T cells, particularly the CD8+
and CD4+CD8+ DP T cell subpopulation.
DISCUSSION
NK cells are best known for their ability to kill malignant
or viral infected cells, but they have also the capacity to
stimulate the adaptive immune response. On the one hand,
they can produce IFNγ upon activation, thereby steering the
adaptive immune response toward a Th1 response. On the
other hand, there is evidence that, at least in human and
pig, NK cell subsets can perform activities that resemble
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FIGURE 3 | MHC II and CD80/86 expression on porcine NK cells before vaccination and after primary and booster vaccination. (A) Histograms show MHC II (upper
panel) and CD80/86 (lower panel) expression on NK cells within the PBMC population before vaccination (pre-vaccination) and 3 days post primary vaccination
(dppv). An overlay of the signals (pre-vaccination: black open histogram; 3 dppv: red open histogram) and isotype controls (pre-vaccination: gray shaded histogram; 3
dppv: red shaded histogram) of three mock-vaccinated animals (left) and three PRV-vaccinated animals (right) is shown. Graphs show MFI values of MHC II (B) and
CD80/86 (C) expression on porcine NK cells before vaccination, 1, 3, and 18 days post primary vaccination and 1 and 3 days post booster vaccination. The MFI value
of the time point before vaccination was set to 100% and the following time points were compared with the time point before vaccination. (D) Dot plot shows the
percentage of NK cells within the PBMC population before vaccination, 1, 3, and 18 days post primary vaccination and 1 and 3 days post booster vaccination. Dot
plot shows the results of three animals of each group (mock-vaccinated and PRV-vaccinated group) and the mean values are connected with a line. P-value threshold
for statistically significant differences was 0.05, p-values are indicated in the graphs (dppv, day(s) post-primary vaccination; dpbv, day(s) post-booster vaccination).
those of professional APCs. Our data show that MHC class
II (and CD80/86) expression on the surface of porcine NK
cells is increased shortly after primary vaccination with an
attenuated PRV vaccine strain, and that NK cells can use this
APC-like activity to stimulate proliferation of PRV-experienced
T cells.
We found that shortly after a primary PRV vaccination of
pigs, at 3 days post vaccination, NK cells in blood showed an
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FIGURE 4 | NK cells from PRV-vaccinated pigs stimulate T cell proliferation of PRV-experienced CD8+ and CD4+CD8+ T cells after killing of PRV-infected target
cells. (A) SK cells were mock-infected or PRV-infected and subsequently incubated with NK cells from mock- or PRV-vaccinated animals for 4 h at a effector:target
ratio of 20:1. Viability of target cells was assessed by propidium iodide and flow cytometry. Dot plots show the results of the three animals in each group (mock- and
PRV-vaccinated) and the mean values are indicated with a horizontal line. (B–D) PRV-stimulated NK cells were either or not co-cultured with medium, mock- or
PRV-infected target SK cells at an effector:target ratio of 20:1. After 2 h co-incubation, violet dye-labeled CD6+ T cells were added and incubated for 4 days. Dot
plots show the T cell proliferation of CD3+ (B), CD8+ (C) CD4+CD8+ (D), and CD4+ (E) T cells of the three animals in each group (left panels: mock-vaccinated
animals, right panels: PRV-vaccinated animals). The mean values are indicated with a horizontal line. Statistically significant differences in T cell proliferation between
NK cells that were pre-incubated with PRV-infected SK target cells vs. mock-infected SK target cells are indicated with asterisks (*p < 0.05; **p < 0.01).
increased cell surface expression of MHC class II. These data
are in line with data on HSV, where it has been shown that in
vitro addition of viral antigens to NK cells triggers increased
expression of MHC class II (15). In our assays, MHC class
II upregulation was associated with an increase, although not
statistically significant, in cell surface expression of the co-
stimulatory CD80/86 molecules.
The significant increase in MHC class II expression (and
non-significant trend of increased CD80/86 expression) observed
early after primary vaccination faded at later time points (18 days
post vaccination). A speculative explanation for this observation
is that after vaccination, the stimulated NK cells may migrate
to the infected tissues and/or to secondary lymphoid organs
where the antigen-bearing NK cells could settle in the T-cell
area where they may stimulate T cells. It will be interesting
in further studies to analyze early after vaccination whether
MHC class II-expressing NK cells can be observed in the
vaccinated tissue and/or in the T-cell areas in the draining
lymph nodes. The increase in MHC class II (and trend of
increased CD80/86 expression) was observed early after primary
vaccination but not after booster vaccination. One speculative
explanation for this observationmay be that at the time of booster
vaccination, neutralizing antibodies and/or T cells can limit virus
replication, resulting in a lower number of viral particles to
stimulate increased expression of MHC II (and/or CD80/86)
on NK cells. Indeed, we found that primary vaccination was
sufficient to induce a PRV-specific T cell response and PRV-
specific serum antibodies (Figure 2). Alternatively at the time
of booster vaccination, it is possible, and even likely, that PRV-
experienced memory T cells are present in the different tissues
that were subjected to vaccination (respiratory tract and skin).
Hence, we cannot exclude that booster vaccination may also
have stimulated APC-like features in local NK cells, but that
these cells remained present in the tissues where they may have
stimulated the pre-existing tissue-resident PRV-specific memory
T cells. In support of the idea that NK cells may stimulate
pre-existing tissue-resident memory T cell responses against
alphaherpesviruses, for HSV, it has been found that a large
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proportion of NK cells (57%) in human recurrent herpetic lesions
were in contact with CD4+ T cells and were suggested to present
antigen to these T cells (15).
We showed that upon killing of PRV-infected target cells,
porcine NK cells are able to stimulate proliferation of CD8+ and
CD4+CD8+ PRV-experienced T cells, especially the CD4+CD8+
DP T cell subpopulation (Figure 4). Proliferation of CD8+ T
lymphocytes may directly contribute to the elimination of PRV-
infected cells, since Zuckermann et al. (27) already have shown
that porcine CD8+ T lymphocytes can kill PRV-infected target
cells (27). Proliferation of the CD4+CD8+ DP T cell subset is
particularly interesting since this special T cell population in pigs
possesses properties ofmature antigen-experienced cells, induced
by stimulation with recall antigen (28), and can have a memory
function (26, 27). This T cell subpopulation has also been shown
to contribute to the production of virus-specific antibodies
against PRV by B cells (29) and appears to display a MHC class
II-restricted cytolytic function upon stimulation with PRV (30).
Not only for PRV, but also for porcine rubulavirus infection,
CD4+CD8+ cells have been reported and may participate in
the defense against virus infection (31). Since CD4+CD8+ T
cells have been reported to arise from CD4+ T cells that can
acquire CD8 expression after antigen encounter (28, 31), future
research aimed at vaccination purposes will have to showwhether
porcine NK cells may not only stimulate expansion of this PRV-
experienced CD4+CD8+ memory T cell population upon re-
encounter and processing of the same antigen, but also if NK cells
can contribute to the priming of naïve CD4+ T-cells.
Of note, both cytolytic CD8+ and antigen-experienced
CD4+CD8+ porcine T cell subsets have been reported to express
MHC II (32–35) A theoretical possibility could be that the T
cells themselves may take up antigen released from infected cells
and present it to each other, thereby contributing to the T cell
proliferation observed in our assays. However, porcine T cells
have not been reported to internalize or present antigen. Since
we showed earlier that PRV causes substantial lysis of infected
SK cells at 24 hpi, reaching 100% lysis at 48 hpi (22), the 4
day proliferation assays performed in the current study would
allow sufficient time for T cells to internalize and present antigen.
However, we found no evidence for T cell proliferation when
T cells were added to PRV-infected SK cells in the absence of
NK cells in the 4 day proliferation assays, whereas significant
T cell proliferation could be observed in the presence of NK
cells (Figures 4B–D), arguing against the hypothesis of T cell
presentation of PRV antigens in these assays.
Human NK cells have been suggested to present antigen
to and stimulate T cell responses against HSV and several
other reports indicate that some human NK cell subsets may
express MHC II and co-stimulatory molecules that stimulate
T cell proliferation (12, 13, 15, 36–40). In this context, our
data are the first to directly show that NK cells indeed can
stimulate proliferation of alphaherpesvirus-experienced T cells
upon killing of alphaherpesvirus-infected target cells. These data
underline the notion that the pig may be a particularly interesting
model to address this less-well known aspect of NK cell biology.
In contrast to human and porcine NK cells, murine NK cells
do not express MHC class II or co-stimulatory molecules, but
can acquire these molecules from dendritic cells (DCs) via a
membrane exchange process called trogocytosis (41). Possibly
because of the low quantities of MHC class II and co-stimulatory
molecules that decorate the NK cell surface upon trogocytosis,
MHC class II and co-stimulatory molecules on mouse NK cells
have been associated with suppression of DC-induced CD4+ T-
cell responses (41), which is very different from the stimulation
of T cell proliferation observed in man and pig.
The results obtained in this study highlight the potential
of using the porcine model as a complementary tool to
further investigate the role of innate immune players, like
NK cells, and underestimated features of these cells in
the context of alphaherpesvirus infection to provide key
insights in the development of successful (alphaherpesvirus)
vaccines.
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